Fort Worth, Texas--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), a global eye care leader dedicated to helping people have excellent vision, will Showcasing its latest developments in integrated and interconnected surgical technology-Alcon's smart solutions, a digital platform specifically designed for ophthalmology-at the upcoming American Academy of Ophthalmology (AAO) 2021 annual meeting. This new platform further strengthens Alcon's leading position in clinic-to-operating room (OR) integration through image-guided technology and cloud-based planning. The conference will also introduce the key data of leading surgical equipment, ARGOS® biometer with image guidance and Optiwave refraction analysis (ORA) SYSTEM®.
SMARTCataract will be shown to American ophthalmologists at AAO 2021
Alcon will demonstrate SMARTCataract live, which is the first application under Alcon’s SMART Solutions platform. The key elements of this new type of application include planning, connection, analysis and optimization-all of which are designed to achieve greater efficiency, reliability and accuracy. 1-5†
The application combines the data system and most diagnostic equipment (including the ARGOS biometer with image guidance) with Alcon’s cataract surgery equipment (including LenSx® femtosecond laser and LuxOR® Revalia™ ophthalmic microscope) and the most commonly used third The tripartite microscope (from the clinic) is connected to the operating room and back.
Alcon plans to introduce more connections in the operating room through the ORA system and NGENUITY® 3D visualization system in the near future.
"Alcon’s SMARTCataract app can now provide us with the tools to link our biometric instruments and medical records with the most modern IOL formulas, so the most advanced surgical planning, even for post-refractive patients, is only It takes a fraction of the time it takes. Moreover, we can almost eliminate the manual data transfer from one device to another, giving us peace of mind, because transcription errors are a thing of the past," said Dr. John Hovanesian of the Harvard Ophthalmology Association . "For my practice, this means being confident in our surgical results and a better patient experience."
SMART Solutions utilizes the open, cloud-based infrastructure and services of Philips HealthSuite based on Amazon Web Services (AWS) to enable surgeons to aggregate, organize, and analyze all relevant issues in an integrated application designed for security and remote planning data.
Sergio Duplan, President of Alcon North America, said: "As a global leader in eye care, we will continue to push the boundaries of technology to help improve the efficacy and accuracy of cataract surgery. "We are working with the industry. Experts inside and outside cooperate, based on our existing ecosystem, and continue to make progress in this field. "
Alcon will expand to more U.S. customers before the end of this year, and launch it more widely in 2022. For more information about SMART Solutions and SMARTCataract applications, please visit AlconSMARTSolutions.com.
Using ORA SYSTEM and Barrett True K Formula 6 can achieve excellent refractive results
ORA SYSTEM is the only intraoperative aberrometer on the market. With the first and only database for real-time intraocular lens (IOL) calculations during cataract surgery, ORA SYSTEM currently includes more than 2 million cases.
A new retrospective analysis of 1,067 eyes implanted with AcrySof® IQ single-focal intraocular lenses showed that compared with Barret True K alone, intraoperative aberration measurements achieved better results in LASIK/PRK eyes after myopia Refractive results (measured as absolute prediction error p<0.005). 6 Constantly ORA SYSTEM has optimized its growing database of millions of cases, helping surgeons capture outliers in real time and accurately hit refractive targets before IOL implantation. 7 Another study on the ORA system will be introduced:
ARGOS achieves an excellent acquisition rate that is superior to Lenstar* and IOLMaster* biometers; proven to save time for faster and smarter planning8-16
ARGOS is an industry-leading swept frequency source optical coherence tomography (SS-OCT) biometer, equipped with image guidance, which can provide faster and smarter planning solutions. 9-12, 15
The data from "The Impact of Optical Biometer Time Efficiency on Cataract Evaluation and Surgery: Time and Movement Research" will emphasize that ARGOS provides considerable time efficiency for cataract surgery practice, surgeons, and patients through its excellent acquisition rate and integrated functions. 17 The time and movement research presented at AAO will prove that ARGOS can improve the efficiency of evaluating cataract patients by measuring time and reducing the need for manual A-scans. 8,10
The complete summary book, registration link for on-site events and booth information can all be found on MyAlconatAAO.com.
Alcon’s SMART Solutions is a comprehensive cloud-based digital health solutions platform designed specifically for ophthalmology practice. Through its SMARTCataract app, it can automatically evaluate patient data and surgeon preferences to make the best recommendations, thereby improving surgical accuracy and bringing better patient outcomes for cataract treatment. Surgeons and their staff should refer to the equipment product manual for important product information.
About the ARGOS® biometer with image guidance
ARGOS is a non-invasive, non-contact biometer based on swept frequency source optical coherence tomography (SS-OCT). The device is designed to obtain eye measurements and perform calculations to determine the appropriate intraocular lens (IOL) power and type for implantation during intraocular lens placement. For a complete description of proper use and maintenance, optical and technical specifications, and a complete list of warnings and precautions, please refer to the ARGOS User Manual.
About Optiwave Refraction Analysis (ORA) SYSTEM®
ORA SYSTEM technology uses wavefront aberration measurement data to measure and analyze the refractive power of the eye (ie spherical, cylindrical and axial measurements) to support cataract surgery. Surgeons should refer to the ORA SYSTEM operating manual for complete instructions for proper use and maintenance, as well as a complete list of warnings and precautions.
Alcon helps people see better. As a global leader in the field of eye care with more than seven years of history, we provide the broadest product portfolio to enhance vision and improve people's lives. Our surgical and vision care products affect the lives of more than 260 million people suffering from cataracts, glaucoma, retinal diseases and refractive errors in more than 140 countries every year. Our more than 23,000 employees are improving the quality of life through innovative products, collaboration with eye care professionals, and programs that promote quality eye care. Learn more on www.alcon.com.
†Enable via ALCON®'s integrated image guidance.
*Trademarks are the property of their respective owners.
Note on forward-looking statements
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be used such as "expect", "intend", "commitment", "expect", "maintenance", "plan", "target", "seek", "believe", "project", "estimate", "Expect", "strategy", "future", "may", "may", "should", "will" and similar references to future periods.
Forward-looking statements are neither historical facts nor guarantees of future performance. Instead, they are based solely on our current beliefs, expectations, and assumptions about the future of the business, future plans and strategies, and other future conditions. Because forward-looking statements are related to the future, they are subject to inherent uncertainties and risks that are difficult to predict. We discussed some of these factors in our filing with the US Securities and Exchange Commission, including our Form 20-F. If one or more of these uncertainties or risks become reality, or if the basic assumptions prove to be incorrect, the actual results may differ materially from the expected results. Therefore, you should not rely on any of these forward-looking statements.
The forward-looking statements in this press release are only published on the date of submission, and we assume no obligation to update the forward-looking statements due to new information, future events, or other reasons.
Connect with us on Facebook LinkedIn
Investor Relations Karen King 41 589 112 110 (Geneva) 1 817 615 2789 (Fort Worth) investor.relations@alcon.com
Media Relations Blake Overby 1 817 551 4328 (Fort Worth) 1 682 321 2897 (Fort Worth) blake-1.overby@alcon.com
Alcon showcases the latest developments in cataract integration and connectivity at AAO 2021
Investor Relations Karen King 41 589 112 110 (Geneva) 1 817 615 2789 (Fort Worth) investor.relations@alcon.com
Media Relations Blake Overby 1 817 551 4328 (Fort Worth) 1 682 321 2897 (Fort Worth) blake-1.overby@alcon.com